Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion

Publisher： Karger

E-ISSN： 1423-0267|236|4|228-234

ISSN： 0030-3755

Source： Ophthalmologica, Vol.236, Iss.4, 2016-11, pp. : 228-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Ranibizumab and Aqueous Humor Factors/Cytokines in Major and Macular Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 235, Iss. 4, 2016-03 ,pp. : 203-207

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 227, Iss. 3, 2011-12 ,pp. : 132-138

Karger

Access to resources Recommend Favorite

Intravitreal Triamcinolone for Cystoid Macular Edema Related to Branch Retinal Vein Occlusion

By  

Annals of Ophthalmology, Vol. 38, Iss. 4, 2006-12 ,pp. : 317-320

Humana Press, Inc

Access to resources Recommend Favorite

Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 216-222

Karger

Access to resources Recommend Favorite